Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Philip C. Prorok(National Cancer Institute), Gerald L. Andriole(Washington University in St. Louis), Robert S. Bresalier(Henry Ford Health System), Saundra S. Buys(University of Utah), David Chia(UCLA Health), E. David Crawford(University of Colorado Health), Ronald Fogel(Henry Ford Health System), Edward P. Gelmann(Georgetown University), Fred Gilbert(Pacific Health Research and Education Institute), Marsha Hasson(Westat (United States)), Richard B. Hayes(National Cancer Institute), Christine Cole Johnson(Henry Ford Health System), Jack S. Mandel(University of Minnesota), Albert Oberman(University of Alabama at Birmingham), Barbara O’Brien(Westat (United States)), Martin M. Oken(Minnesota Oncology), Sameer Rafla(Brooklyn College), Douglas J. Reding(Marshfield Clinic), Wilmer M. Rutt(Henry Ford Health System), Joel L. Weissfeld(UPMC Hillman Cancer Center), Lance Yokochi(Pacific Health Research and Education Institute), John K. Gohagan(National Cancer Institute)
Controlled Clinical Trials
December 1, 2000
Cited by 1,037

Abstract


Related Papers

No related papers found

Powered by citation graph analysis